Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Travis

Showing results (101-110 of 107) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 107 results.
Nature Reviews. Gastroenterology & Hepatology|October 3, 2023
Precision medicine in monogenic inflammatory bowel disease: proposed mIBD REPORT standardsHolm H Uhlig, Claire Booth, Judy Cho, et al.
Nature Medicine|October 22, 2021
IL-1-driven stromal-neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapiesMatthias Friedrich, Mathilde Pohin, Matthew A Jackson, et al.
JNCI Cancer Spectrum|July 23, 2025
Impact of postoperative fluorodeoxyglucose positron emission tomography/computed tomography on adjuvant head and neck cancer treatmentP Travis Courtney, Jesus E Juarez Casillas, Eulanca Y Liu, et al.
Gastroenterology|April 1, 2020
Deep Remission at 1 Year Prevents Progression of Early Crohn's DiseaseRyan C Ungaro, Clara Yzet, Peter Bossuyt, et al.
Nature Communications|June 22, 2022
Author Correction: Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel diseaseEva Gonçalves Serra, Tobias Schwerd, Loukas Moutsianas, et al.
Nature Communications|February 22, 2020
Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel diseaseEva Gonçalves Serra, Tobias Schwerd, Loukas Moutsianas, et al.
Gastroenterology|July 5, 2022
CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease, Christopher Ma, Jurij Hanzel, et al.
Pageof 11

Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
Nature Reviews. Gastroenterology & Hepatology|October 3, 2023
Precision medicine in monogenic inflammatory bowel disease: proposed mIBD REPORT standardsHolm H Uhlig, Claire Booth, Judy Cho, et al.
Nature Medicine|October 22, 2021
IL-1-driven stromal-neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapiesMatthias Friedrich, Mathilde Pohin, Matthew A Jackson, et al.
JNCI Cancer Spectrum|July 23, 2025
Impact of postoperative fluorodeoxyglucose positron emission tomography/computed tomography on adjuvant head and neck cancer treatmentP Travis Courtney, Jesus E Juarez Casillas, Eulanca Y Liu, et al.
Gastroenterology|April 1, 2020
Deep Remission at 1 Year Prevents Progression of Early Crohn's DiseaseRyan C Ungaro, Clara Yzet, Peter Bossuyt, et al.
Nature Communications|June 22, 2022
Author Correction: Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel diseaseEva Gonçalves Serra, Tobias Schwerd, Loukas Moutsianas, et al.
Nature Communications|February 22, 2020
Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel diseaseEva Gonçalves Serra, Tobias Schwerd, Loukas Moutsianas, et al.
Gastroenterology|July 5, 2022
CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease, Christopher Ma, Jurij Hanzel, et al.
Pageof 11